{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:51:33Z","timestamp":1792039893151,"version":"4.4.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"vor","delay-in-days":250,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["465763\/2014-6"],"award-info":[{"award-number":["465763\/2014-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010749","name":"Comiss\u00e3o Nacional de Energia Nuclear","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010749","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/08194-2"],"award-info":[{"award-number":["2018\/08194-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nitric Oxide"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.niox.2021.04.008","type":"journal-article","created":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T02:46:19Z","timestamp":1619837179000},"page":"31-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Nitric-oxide releasing chitosan nanoparticles towards effective treatment of cutaneous leishmaniasis"],"prefix":"10.1016","volume":"113-114","author":[{"given":"Fernanda V.","family":"Cabral","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena T.","family":"Pelegrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amedea B.","family":"Seabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4203-1134","authenticated-orcid":false,"given":"Martha S.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.niox.2021.04.008_bib1","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.niox.2021.04.008_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005739","article-title":"A new perspective on cutaneous leishmaniasis-Implications for global prevalence and burden of disease estimates","volume":"11","author":"Bailey","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.niox.2021.04.008_bib4","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host-pathogen interface","volume":"9","author":"Kaye","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.niox.2021.04.008_bib5","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.3390\/ijms18061296","article-title":"Cutaneous manifestations of human and murine leishmaniasis","volume":"18","author":"Scorza","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.niox.2021.04.008_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007152","article-title":"Host and parasite responses in human diffuse cutaneous leishmaniasis caused by L. amazonensis","volume":"13","author":"Christensen","year":"2019","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.niox.2021.04.008_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: a 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.niox.2021.04.008_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.actatropica.2011.02.007","article-title":"Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World","volume":"118","author":"Oliveira","year":"2011","journal-title":"Acta Trop."},{"key":"10.1016\/j.niox.2021.04.008_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis","volume":"7","author":"Reithinger","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.niox.2021.04.008_bib10","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2230.2004.01605.x","article-title":"The psychological impact of cutaneous leishmaniasis","volume":"29","author":"Yanik","year":"2004","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.niox.2021.04.008_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223313","article-title":"The impact of leishmaniasis on mental health and psychosocial well-being: a systematic review","volume":"14","author":"Pires","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.niox.2021.04.008_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/S0035-9203(00)90341-9","article-title":"A topical nitric oxide-generating therapy for cutaneous leishmaniasis","volume":"94","author":"Davidson","year":"2000","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.niox.2021.04.008_bib13","doi-asserted-by":"crossref","DOI":"10.3109\/09546634.2010.495380","article-title":"Is topical nitric oxide and cryotherapy more effective than cryotherapy in the treatment of old world cutaneous leishmaniasis?","volume":"23","author":"Jowkar","year":"2012","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.niox.2021.04.008_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/nri.2016.72","article-title":"Cutaneous leishmaniasis: immune responses in protection and pathogenesis","volume":"16","author":"Scott","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.niox.2021.04.008_bib15","doi-asserted-by":"crossref","first-page":"2496713","DOI":"10.1155\/2020\/2496713","article-title":"Review on the role of host immune response in protection and immunopathogenesis during cutaneous leishmaniasis infection","volume":"2020","author":"Dubie","year":"2020","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.niox.2021.04.008_bib16","doi-asserted-by":"crossref","first-page":"203818","DOI":"10.1155\/2012\/203818","article-title":"Reactive oxygen species and nitric oxide in cutaneous leishmaniasis","volume":"2012","author":"Horta","year":"2012","journal-title":"J. Parasitol. Res."},{"key":"10.1016\/j.niox.2021.04.008_bib17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1006\/expr.1997.4151","article-title":"Leishmania spp.: nitric oxide-mediated metabolic inhibition of promastigote and axenically grown amastigote forms","volume":"86","author":"Lemesre","year":"1997","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.niox.2021.04.008_bib18","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.pt.2015.08.001","article-title":"Induction, propagation, and activity of host nitric oxide: lessons from Leishmania infection","volume":"31","author":"Olekhnovitch","year":"2015","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.niox.2021.04.008_bib19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2174\/1389557516666160808124624","article-title":"Nanoparticulated nitric oxide donors and their biomedical applications","volume":"17","author":"Seabra","year":"2017","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.niox.2021.04.008_bib20","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.2174\/0929867323666160729104647","article-title":"Nitric oxide-releasing biomaterials for biomedical applications","volume":"23","author":"Zhou","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.niox.2021.04.008_bib21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4103\/2045-9912.273956","article-title":"Recent developments in nitric oxide-releasing biomaterials for biomedical applications","volume":"9","author":"Yu","year":"2019","journal-title":"Med. Gas Res."},{"key":"10.1016\/j.niox.2021.04.008_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.niox.2019.09.007","article-title":"Nitric oxide-loaded chitosan nanoparticles as an innovative antileishmanial platform","volume":"93","author":"Cabral","year":"2019","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.niox.2021.04.008_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11051-017-3747-4","article-title":"Nitric oxide-releasing nanoparticles: synthesis, characterization, and cytotoxicity to tumorigenic cells","volume":"19","author":"Pelegrino","year":"2017","journal-title":"J. Nanoparticle Res."},{"key":"10.1016\/j.niox.2021.04.008_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.niox.2016.09.010","article-title":"Nitric oxide-releasing chitosan nanoparticles alleviate the effects of salt stress in maize plants","volume":"61","author":"Oliveira","year":"2016","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.niox.2021.04.008_bib25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1039\/C6MD00502K","article-title":"Chitosan nanoparticles for nitric oxide delivery in human skin","volume":"8","author":"Pelegrino","year":"2017","journal-title":"MedChemComm"},{"key":"10.1016\/j.niox.2021.04.008_bib26","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/php.13188","article-title":"Preclinical investigation of methylene blue-mediated antimicrobial photodynamic therapy on Leishmania parasites using real-time bioluminescence","volume":"96","author":"Cabral","year":"2020","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.niox.2021.04.008_bib27","first-page":"1","article-title":"Building, testing and validating a set of home-made von Frey filaments: a precise, accurate and cost-effective alternative for nociception assessment","volume":"232","author":"Sousa","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.niox.2021.04.008_bib28","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.niox.2019.11.003","article-title":"Delivering nitric oxide into human skin from encapsulated S-nitrosoglutathione under UV light: an in vitro and ex vivo study","volume":"94","author":"Pelegrino","year":"2020","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.niox.2021.04.008_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003889","article-title":"A Review: the current in vivo models for the discovery and utility of new anti-leishmanial drugs targeting cutaneous leishmaniasis","volume":"9","author":"Mears","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.niox.2021.04.008_bib30","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri933","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.niox.2021.04.008_bib31","article-title":"Animal models for the analysis of immune responses to leishmaniasis","volume":"19","author":"Sacks","year":"2001","journal-title":"Curr. Protoc. Im."},{"key":"10.1016\/j.niox.2021.04.008_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12026-007-8012-y","article-title":"L-arginine metabolism and its impact on host immunity against Leishmania infection","volume":"41","author":"Wanasen","year":"2008","journal-title":"Immunol. Res."},{"key":"10.1016\/j.niox.2021.04.008_bib33","doi-asserted-by":"crossref","first-page":"2603730","DOI":"10.1155\/2019\/2603730","article-title":"Cutaneous leishmaniasis: the complexity of host's effective immune response against a polymorphic parasitic disease","volume":"2019","author":"Gabriel","year":"2019","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.niox.2021.04.008_bib34","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3390\/polym10040462","article-title":"Biomedical applications of chitosan and its derivative nanoparticles","volume":"10","author":"Zhao","year":"2018","journal-title":"Polymers"},{"key":"10.1016\/j.niox.2021.04.008_bib35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/intimm\/dxx075","article-title":"How to master the host immune system? Leishmania parasites have the solutions!","volume":"30","author":"Rossi","year":"2017","journal-title":"Int. Immunol."},{"key":"10.1016\/j.niox.2021.04.008_bib36","doi-asserted-by":"crossref","first-page":"19699","DOI":"10.1074\/jbc.R110.101618","article-title":"What part of NO don't you understand? Some answers to the cardinal questions in nitric oxide biology","volume":"285","author":"Hill","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.niox.2021.04.008_bib37","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nrmicro1004","article-title":"Antimicrobial reactive oxygen and nitrogen species: concepts and controversies","volume":"2","author":"Fang","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.niox.2021.04.008_bib38","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nrm1569","article-title":"Protein S-nitrosylation: purview and parameters","volume":"6","author":"Hess","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.niox.2021.04.008_bib39","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1089\/ars.2017.7403","article-title":"Protein S-nitrosylation: determinants of specificity and enzymatic regulation of S-nitrosothiol-based signaling","volume":"30","author":"Stomberski","year":"2019","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.niox.2021.04.008_bib40","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.bbrc.2004.01.113","article-title":"Kinetics of parasite cysteine proteinase inactivation by NO-donors","volume":"315","author":"Bocedi","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.niox.2021.04.008_bib41","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/exd.13098","article-title":"Topical treatment with a two-component gel releasing nitric oxide cures C57BL\/6 mice from cutaneous leishmaniasis caused by Leishmania major","volume":"25","author":"Butsch","year":"2016","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.niox.2021.04.008_bib42","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1093\/jac\/dkt210","article-title":"S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions","volume":"68","author":"Costa","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.niox.2021.04.008_bib43","doi-asserted-by":"crossref","first-page":"e01772","DOI":"10.1128\/AAC.01772-19","article-title":"Activity of chitosan and its derivatives against Leishmania major and Leishmania mexicana in vitro","volume":"64","author":"Riezk","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.niox.2021.04.008_bib44","doi-asserted-by":"crossref","first-page":"105045","DOI":"10.1016\/j.actatropica.2019.105045","article-title":"Paromomycin-loaded mannosylated chitosan nanoparticles: synthesis, characterization and targeted drug delivery against leishmaniasis","volume":"197","author":"Esfandiari","year":"2019","journal-title":"Acta Trop."},{"key":"10.1016\/j.niox.2021.04.008_bib45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jddst.2017.10.016","article-title":"S-nitrosoglutathione-containing chitosan nanoparticles dispersed in pluronic F-127 hydrogel: potential uses in topical applications","volume":"43","author":"Pelegrino","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.niox.2021.04.008_bib46","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/0883911516681329","article-title":"Chitosan-based silver nanoparticles: a study of the antibacterial, antileishmanial and cytotoxic effects","volume":"32","author":"Lima","year":"2017","journal-title":"J. Bioact. Compat Polym."},{"key":"10.1016\/j.niox.2021.04.008_bib47","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1080\/10717544.2019.1692968","article-title":"Nanoparticles for antiparasitic drug delivery","volume":"26","author":"Sun","year":"2019","journal-title":"Drug Deliv."},{"key":"10.1016\/j.niox.2021.04.008_bib48","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.2147\/IJN.S142060","article-title":"Intracellular disposition of chitosan nanoparticles in macrophages: intracellular uptake, exocytosis, and intercellular transport","volume":"12","author":"Jiang","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.niox.2021.04.008_bib49","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3390\/pharmaceutics12040371","article-title":"Endocytosis: the nanoparticle and submicron nanocompounds gateway into the cell","volume":"12","author":"Manzanares","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.niox.2021.04.008_bib50","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.3390\/molecules25174002","article-title":"Activity of amphotericin B-loaded chitosan nanoparticles against experimental cutaneous leishmaniasis","volume":"25","author":"Riezk","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.niox.2021.04.008_bib51","first-page":"538","article-title":"Topical treatment for cutaneous leishmaniasis","volume":"3","author":"Garnier","year":"2002","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.niox.2021.04.008_bib52","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00436-016-5340-7","article-title":"Leishmania infection: painful or painless?","volume":"116","author":"Borghi","year":"2017","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.niox.2021.04.008_bib53","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0304-3959(99)00297-3","article-title":"Hyperalgesia and upregulation of cytokines and nerve growth factor by cutaneous leishmaniasis in mice","volume":"85","author":"Kanaan","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.niox.2021.04.008_bib54","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.exppara.2006.01.003","article-title":"Leishmania major: low infection dose causes short-lived hyperalgesia and cytokines upregulation in mice","volume":"113","author":"Karam","year":"2006","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.niox.2021.04.008_bib55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jneuroim.2006.11.003","article-title":"Interleukin-10 reduces hyperalgesia and the level of interleukin-1 beta in BALB\/c mice infected with Leishmania major with no major effect on the level of interleukin-6","volume":"183","author":"Karam","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.niox.2021.04.008_bib56","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1574-695X.2007.00329.x","article-title":"The role of nitric oxide in inflammatory reactions","volume":"51","author":"Tripathi","year":"2007","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.niox.2021.04.008_bib57","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0885-3924(97)00178-4","article-title":"Role of nitric oxide in the physiopathology of pain","volume":"14","author":"Anbar","year":"1997","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.niox.2021.04.008_bib58","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.niox.2011.06.004","article-title":"Pain and analgesia: the dual effect of nitric oxide in the nociceptive system","volume":"25","author":"Cury","year":"2011","journal-title":"Nitric Oxide"}],"container-title":["Nitric Oxide"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860321000434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860321000434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:06:39Z","timestamp":1761069999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089860321000434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":57,"alternative-id":["S1089860321000434"],"URL":"https:\/\/doi.org\/10.1016\/j.niox.2021.04.008","relation":{},"ISSN":["1089-8603"],"issn-type":[{"value":"1089-8603","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitric-oxide releasing chitosan nanoparticles towards effective treatment of cutaneous leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Nitric Oxide","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.niox.2021.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}